A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
This study tests new medications to see if they are safe and helpful for adults hospitalized with COVID-19. By comparing these treatments against a placebo or standard care, researchers hope to find better ways to help patients recover faster.
You might be able to join if you are 18 or older, currently in the hospital with a confirmed COVID-19 infection, and you or your representative agrees to follow the study rules. However, people with certain breathing difficulties or advanced lung issues from the virus may not be eligible.
During the study, you will receive either an experimental treatment or a placebo, which is an inactive substance that looks like the real medicine. Doctors and researchers will closely monitor your health and recovery time to see how well the treatment works.
This study took place at multiple medical centers globally, including locations in Alabama and California within the United States. Please note that this clinical trial has now been completed.
- 1The study tests new treatments for hospitalized adults with COVID-19.
- 2Participants receive either an investigational medicine or a placebo while being closely monitored.
- 3This clinical trial is already completed and has finished collecting data.
No related links yet
Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.
Suggest a linkThis summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.